Given the strong association between anti-TPO titers and the risk of developing clinically overt hypothyroidism, screening is recommended in patients with intensely positive antibody titers and NSV, and annual thyroid function testing is warranted in patients with antibody titers > 800 kU/L at initial screening [27]. Here, TPO is linked to hypothyroidism.